株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の抗生物質市場:2020年~2024年の予測

Global Antibiotics Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 312950
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
世界の抗生物質市場:2020年~2024年の予測 Global Antibiotics Market 2020-2024
出版日: 2020年03月17日 ページ情報: 英文 120 Pages
概要

世界の抗生物質市場は、予測期間中に3%のCAGRで成長する見通しで、2024年には44億4,000万米ドルに達すると予測されています。同市場の成長は、感染症の有病率の上昇に牽引されています。さらに、さまざまな疾患とその治療に対する認識の高まりが、予測期間中の同市場の成長を後押しするものと期待されています。

当レポートは世界の抗生物質市場について調査しており、市場の動向や課題、成長要因、用途・製品・由来・作用メカニズム・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2019年
  • 市場の見通し:2019-2024年の予測

ポーターのファイブフォース分析

市場セグメンテーション:製品別

  • 市場セグメンテーション
  • 比較
  • 広域抗生物質
  • 狭域抗生物質
  • 市場機会

市場セグメンテーション:用途別

  • 市場セグメンテーション
  • 比較
  • ヒト用
  • 動物用
  • 市場機会

市場セグメンテーション:由来別

  • 市場セグメンテーション
  • 比較
  • 天然
  • 半合成
  • 合成
  • 市場機会

市場セグメンテーション:作用メカニズム別

  • 市場セグメンテーション
  • 比較
  • 静菌剤
  • 殺菌剤
  • 市場機会

顧客情勢

  • 概要

地域別情勢

  • 市場セグメンテーション
  • 比較
  • アジア太平洋地域
  • 北米
  • 欧州
  • 南米
  • 中東・アフリカ
  • 主要国
  • 市場機会

市場成長要因、課題、および動向

  • 市場成長要因
  • 取引量成長要因:需要主導の成長
  • 取引量成長要因:供給主導の成長
  • 取引量成長要因:外部要因
  • 取引量成長要因:関連市場での需要の移行
  • 価格成長要因:インフレ
  • 価格成長要因:低価格から高価格への移行
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 情勢の革新
  • ベンダー分析

対象ベンダー

  • ベンダーの市場における位置づけ
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi

付録

目次
Product Code: IRTNTR41323

Technavio has been monitoring the global antibiotics market 2020-2024 and it is poised to grow by USD 4.44 bn during 2020-2024, progressing at a CAGR of 3% during the forecast period. Our reports on global antibiotics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of infectious diseases. In addition, growing awareness of various diseases and its treatment is anticipated to boost the growth of the global antibiotics market 2020-2024 as well.

Market Segmentation

Technavio's ‘ global antibiotics market 2020-2024 ’ is segmented as below:

Application:

  • Antibiotics For Human Use
  • Antibiotics For Veterinary Use

Product:

  • Broad-spectrum Antibiotics
  • Narrow-spectrum Antibiotics

Drug Origin:

  • Natural
  • Semi-synthetic
  • Synthetic

Action Mechanism:

  • Bacteriostatic
  • Bactericidal

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global antibiotics market 2020-2024 growth

This study identifies growing awareness of various diseases and its treatment as the prime reasons driving the global antibiotics market 2020-2024 growth during the next few years.

Prominent vendors in global antibiotics market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global antibiotics market 2020-2024, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc. and Sanofi .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product placement
  • Broad-spectrum antibiotics - Market size and forecast 2019-2024
  • Narrow-spectrum antibiotics - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Application

  • Market segments
  • Comparison by Application placement
  • Antibiotics for human use - Market size and forecast 2019-2024
  • Antibiotics for veterinary use - Market size and forecast 2019-2024
  • Market opportunity by Application

Market Segmentation by Other 1

  • Market segments
  • Comparison by Other1 placement
  • Natural - Market size and forecast 2019-2024
  • Semisynthetic - Market size and forecast 2019-2024
  • Synthetic - Market size and forecast 2019-2024
  • Market opportunity by Other1

Market Segmentation by Other 2

  • Market segments
  • Comparison by Other2 placement
  • Bacteriostatic - Market size and forecast 2019-2024
  • Bactericidal - Market size and forecast 2019-2024
  • Market opportunity by Other2

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • APAC - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption
  • Vendor Analysis

Vendors covered

  • Market positioning of vendors
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Key Finding 9
  • 9.Key Finding 10
  • 10.Key Finding 11
  • 11.Market in focus
  • 13.Parent market
  • 16.Market characteristics
  • 18.Offerings of vendors included in the market definition
  • 20.Market segments.
  • 25.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 26.Global market: Year-over-year growth 2019 - 2024 (%)
  • 27.Five forces analysis 2019 & 2024
  • 29.Bargaining power of buyers
  • 30.Bargaining power of suppliers
  • 31.Threat of new entrants
  • 32.Threat of substitutes
  • 33.Threat of rivalry
  • 35.Market condition - Five forces 2019
  • 36.Product placement - Market share 2019-2024 (%)
  • 37.Comparison by Product placement
  • 38.Broad-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion)
  • 39.Broad-spectrum antibiotics - Year-over-year growth 2019-2024 (%)
  • 40.Narrow-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion)
  • 41.Narrow-spectrum antibiotics - Year-over-year growth 2019-2024 (%)
  • 42. Market opportunity by Product
  • 43.Application placement - Market share 2019-2024 (%)
  • 44.Comparison by Application placement
  • 45.Antibiotics for human use - Market size and forecast 2019-2024 ($ billion)
  • 46.Antibiotics for human use - Year-over-year growth 2019-2024 (%)
  • 47.Antibiotics for veterinary use - Market size and forecast 2019-2024 ($ billion)
  • 48.Antibiotics for veterinary use - Year-over-year growth 2019-2024 (%)
  • 49. Market opportunity by Application
  • 50.Other1 placement - Market share 2019-2024 (%)
  • 51.Comparison by Other1 placement
  • 52.Natural - Market size and forecast 2019-2024 ($ billion)
  • 53.Natural - Year-over-year growth 2019-2024 (%)
  • 54.Semisynthetic - Market size and forecast 2019-2024 ($ billion)
  • 55.Semisynthetic - Year-over-year growth 2019-2024 (%)
  • 56.Synthetic - Market size and forecast 2019-2024 ($ billion)
  • 57.Synthetic - Year-over-year growth 2019-2024 (%)
  • 58. Market opportunity by Other1
  • 59.Other2 placement - Market share 2019-2024 (%)
  • 60.Comparison by Other2 placement
  • 61.Bacteriostatic - Market size and forecast 2019-2024 ($ billion)
  • 62.Bacteriostatic - Year-over-year growth 2019-2024 (%)
  • 63.Bactericidal - Market size and forecast 2019-2024 ($ billion)
  • 64.Bactericidal - Year-over-year growth 2019-2024 (%)
  • 65. Market opportunity by Other2
  • 66.Customer landscape
  • 67.Market share by geography 2019-2024 (%)
  • 68.Geographic comparison
  • 70.APAC - Market size and forecast 2019-2024 ($ billion)
  • 71.APAC - Year-over-year growth 2019-2024 (%)
  • 73.North America - Market size and forecast 2019-2024 ($ billion)
  • 74.North America - Year-over-year growth 2019-2024 (%)
  • 76.Europe - Market size and forecast 2019-2024 ($ billion)
  • 77.Europe - Year-over-year growth 2019-2024 (%)
  • 79.South America - Market size and forecast 2019-2024 ($ billion)
  • 80.South America - Year-over-year growth 2019-2024 (%)
  • 82.MEA - Market size and forecast 2019-2024 ($ billion)
  • 83.MEA - Year-over-year growth 2019-2024 (%)
  • 85.Key leading countries
  • 86.Market opportunity by geography ($ billion)
  • 87.Impact of drivers and challenges
  • 88.Vendor landscape
  • 90.Landscape disruption
  • 92.Industry risks
  • 94.Vendors covered
  • 96.Market positioning of vendors
  • 98.Abbott Laboratories - Overview
  • 99.Abbott Laboratories - Business segments
  • 100.Abbott Laboratories - Key offerings
  • 101.Abbott Laboratories - Key customers
  • 102.Abbott Laboratories - Segment focus
  • 104.AbbVie Inc. - Overview
  • 105.AbbVie Inc. - Business segments
  • 106.AbbVie Inc. - Key offerings
  • 107.AbbVie Inc. - Key customers
  • 108.AbbVie Inc. - Segment focus
  • 110.AstraZeneca Plc - Overview
  • 111.AstraZeneca Plc - Business segments
  • 112.AstraZeneca Plc - Key offerings
  • 113.AstraZeneca Plc - Key customers
  • 114.AstraZeneca Plc - Segment focus
  • 116.Bayer AG - Overview
  • 117.Bayer AG - Business segments
  • 118.Bayer AG - Key offerings
  • 119.Bayer AG - Key customers
  • 120.Bayer AG - Segment focus
  • 122.F. Hoffmann-La Roche Ltd. - Overview
  • 123.F. Hoffmann-La Roche Ltd. - Business segments
  • 124.F. Hoffmann-La Roche Ltd. - Key offerings
  • 125.F. Hoffmann-La Roche Ltd. - Key customers
  • 126.F. Hoffmann-La Roche Ltd. - Segment focus
  • 128.Johnson & Johnson - Overview
  • 129.Johnson & Johnson - Business segments
  • 130.Johnson & Johnson - Key offerings
  • 131.Johnson & Johnson - Key customers
  • 132.Johnson & Johnson - Segment focus
  • 134.Mayne Pharma Group Ltd. - Overview
  • 135.Mayne Pharma Group Ltd. - Business segments
  • 136.Mayne Pharma Group Ltd. - Key offerings
  • 137.Mayne Pharma Group Ltd. - Key customers
  • 138.Mayne Pharma Group Ltd. - Segment focus
  • 140.Merck KGaA - Overview
  • 141.Merck KGaA - Business segments
  • 142.Merck KGaA - Key offerings
  • 143.Merck KGaA - Key customers
  • 144.Merck KGaA - Segment focus
  • 146.Pfizer Inc. - Overview
  • 147.Pfizer Inc. - Business segments
  • 148.Pfizer Inc. - Key offerings
  • 149.Pfizer Inc. - Key customers
  • 150.Pfizer Inc. - Segment focus
  • 152.Sanofi - Overview
  • 153.Sanofi - Product and service
  • 154.Sanofi - Key offerings
  • 155.Sanofi - Key customers
  • 156.Sanofi - Segment focus
  • 158.Currency conversion rates for US$
  • 159.Research Methodology
  • 160.Validation techniques employed for market sizing
  • 161.Information sources
  • 162. List of abbreviations